CVE:META Meta Growth (META) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free META Stock Alerts C$0.14 0.00 (0.00%) (As of 11/18/2020) Add Compare Share Share Today's RangeC$0.14▼C$0.1450-Day RangeC$0.14▼C$0.1452-Week RangeC$0.07▼C$0.41Volume58,900 shsAverage Volume560,298 shsMarket CapitalizationC$33.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Meta Growth alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Meta Growth Stock (CVE:META)Meta Growth Corp. operates as a recreational cannabis retailer in Canada. It operates recreational retail cannabis stores under the Meta Cannabis Supply Co. and NewLeaf Cannabis banners to sell cannabis and cannabis related products. The company was formerly known as National Access Cannabis Corp. and changed its name to Meta Growth Corp. in February 2020. Meta Growth Corp. was incorporated in 2014 and is based in Etobicoke, Canada. As of November 18, 2020, Meta Growth Corp. operates as a subsidiary of High Tide Inc.Read More META Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart META Stock News HeadlinesApril 26, 2024 | markets.businessinsider.comMaintaining Buy Rating for Meta Platforms: Sustained Growth and Monetization Amid New Investment CyclesApril 26, 2024 | msn.comStock market today: Wall Street falls on double dose of disappointing economic data, as Meta sinksApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 26, 2024 | msn.comMeta's AI spending tests Facebook's growth-first playbookApril 25, 2024 | barrons.comUS Stocks Tumble On Growth Data As Facebook Parent Meta FallsApril 25, 2024 | fool.comMeta's Earnings Topped Q1 Expectations, But Q2 Outlook DisappointedApril 25, 2024 | forbes.comHow Meta’s $200 Billion Stock Plunge Could Impact WorkersApril 25, 2024 | msn.comDow drops more than 300 points on inflation and growth concerns, Meta drags S&P 500 lower: Live updatesApril 26, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 25, 2024 | msn.comAlphabet earnings preview: All eyes on AI investments, ad market growth as Meta disappointsApril 25, 2024 | msn.comWall Street tumbles after dispiriting data on the economy, as Meta sinksApril 25, 2024 | msn.comDow drops more than 600 points on inflation and growth concerns, heads for biggest drop of the year: Live updatesApril 25, 2024 | seekingalpha.comDid Meta Just Burst The Big-Tech Bubble?April 25, 2024 | marketwatch.comMeta earnings weigh on Magnificent Seven stocks. Here’s why investors shouldn’t panic.April 24, 2024 | marketwatch.comMeta earnings: Stock declines accelerate and could wipe out $200 billion in market capApril 24, 2024 | msn.comMeta Stock Tanks 10% Despite Big Earnings BeatApril 24, 2024 | wsj.comMeta Platforms Earnings Today: What to ExpectApril 24, 2024 | msn.comMeta Q1 earnings preview: Ad growth and AI are front and centerApril 24, 2024 | wsj.comMeta Earnings Today: Why Expectations Are Sky High for Facebook's ParentApril 23, 2024 | markets.businessinsider.comBuy Rating Affirmed for Meta Platforms Amidst Strong Growth and Revenue PotentialApril 23, 2024 | au.investing.comMeta Platforms Q1 earnings preview: Analysts Eye AI advancements, ad growthApril 23, 2024 | finance.yahoo.comMeta (META) To Report Earnings Tomorrow: Here Is What To ExpectApril 23, 2024 | forbes.comUp 36% YTD, What To Expect From Meta Platforms In Q1?April 23, 2024 | msn.comMeta (NASDAQ:META) Q1 Earnings: Here’s What to ExpectApril 23, 2024 | msn.comMeta faces ‘extraordinarily high expectations.’ Can earnings clear the bar?April 22, 2024 | techcrunch.comMeta opens Quest OS to third-party headset makers, taps Lenovo and Xbox as partnersApril 22, 2024 | bloomberg.comTesla, Meta And Other Earnings Will Test Stocks’ Recent SelloffSee More Headlines Receive META Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Meta Growth and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCVE:META CUSIPN/A CIKN/A Webwww.metagrowth.com Phone647-689-6382FaxN/AEmployees301Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio1,112.33 Current Ratio4.29 Quick Ratio2.94 Sales & Book Value Annual SalesC$60.96 million Price / Sales0.54 Cash FlowC$0.06 per share Price / Cash Flow2.33 Book ValueC$0.02 per share Price / Book8.24Miscellaneous Outstanding Shares236,680,000Free FloatN/AMarket CapC$33.14 million OptionableNot Optionable BetaN/A The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Mark GoligerCEO & DirectorMr. Michael Cosic C.F.A. (Age 52)M.B.A., MBA, CFA, Chief Financial Officer Comp: $125kMr. Christopher KaneChief Operating OfficerMs. Joy AvzarVP of Legal CounselMr. Matthew RyanVP of MarketingMr. Michael John SalikenCorp. Sec. & DirectorMr. John GillisConsultantMore ExecutivesKey CompetitorsInMed PharmaceuticalsTSE:INMediPharm LabsTSE:LABSZomedica Pharmaceuticals Corp. (ZOM.V)CVE:ZOMViridium Pacific GroupCVE:VIRMedexus PharmaceuticalsTSE:MDPView All Competitors META Stock Analysis - Frequently Asked Questions How have META shares performed in 2024? Meta Growth's stock was trading at C$0.14 at the start of the year. Since then, META stock has increased by 0.0% and is now trading at C$0.14. View the best growth stocks for 2024 here. What other stocks do shareholders of Meta Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Meta Growth investors own include Cargojet (CGJTF), Cogeco Communications (CCA), Alibaba Group (BABA), Alimentation Couche-Tard (ATD.B), Aphria (APHA), Albemarle (ALB), Advanced Energy Industries (AEIS), ACM Research (ACMR) and Aurora Cannabis (ACB). How do I buy shares of Meta Growth? Shares of META stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:META) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Meta Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
